News Focus
News Focus
Replies to #22017 on Biotech Values
icon url

DewDiligence

01/14/06 10:21 PM

#22019 RE: swampboots #22017

Re: RHEO

To be clear: I’m not saying that RHEO’s procedure for dry AMD is definitely worthless, but rather that I’d be willing to bet against it by shorting RHEO if I were able to do so. (I’m not because the stock is non-shortable at my broker.)

For the sake of patients, I hope that RHEO’s procedure does work.